Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdvanced Medical Solutions Group Regulatory News (AMS)

Share Price Information for Advanced Medical Solutions Group (AMS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 194.20
Bid: 193.40
Ask: 194.00
Change: 4.80 (2.53%)
Spread: 0.60 (0.31%)
Open: 191.40
High: 195.80
Low: 189.60
Prev. Close: 189.40
AMS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Jul 2013 15:15

RNS Number : 5437I
Advanced Medical Solutions Grp PLC
03 July 2013
 



3 July 2013

Advanced Medical Solutions Group plc ("AMS" or the "Company")

Exercise of share options and Directors' dealings

Advanced Medical Solutions Group plc (AIM:AMS), the global medical technology company, today announces that following the successful achievement of certain performance criteria, the following options from certain share incentive schemes have been exercised as outlined below.

In order to cover the exercise cost and the tax payable on this exercise Don Evans, Chairman, has sold Ordinary Shares of 5p each on 2 July 2013 as detailed below.

Long Term Incentive Plan (LTIP)

Director

No. of LTIPs prior to exercise

LTIPs exercised

LTIPs after exercise

Don Evans, Chairman

256,713

256,713

-

Deferred Share Bonus Plan (DSB)

Director

No. of DSBs prior to exercise

DSBs exercised

DSBs after exercise

Don Evans, Chairman

128,587

124,176

4,411

The Company has also been informed that Pamela Evans, wife of Don Evans, Chairman, has sold 183,928 Ordinary Shares of 5p each at 74.13p per share. As a result of these transactions Don Evans beneficial interest in the Company has increased from 3,162,587 shares to 3,188,511 shares.

Directors' Dealings in shares

Director

Holding prior to exercise

Holding following exercise

Number of shares sold

Sale Price(p)

Resultant holding

% of issued share capital

Don Evans, Chairman

3,162,587

3,543,476

354,965

74.13p

3,188,511

1.5

The Company also announces that Christopher Meredith, Chief Executive Officer, purchased 2,023 Ordinary Shares of 5p each at 74.13p per share as part of the Deferred Share Bonus Plan. Under the terms of the Plan, the shares will be held in trust on his behalf.

Following this transaction the beneficial ownership of Christopher Meredith is as follows:

Director

Date purchased

Shares Purchased

Resultant Holding

% of issued share capital

Christopher Meredith, CEO

2 July 2013

2,023

1,142,275

0.6

For further information:

Advanced Medical Solutions Group plc

Mary Tavener, Group Finance Director +44 (0) 1606 545 508

Investec (NOMAD)

Daniel Adams +44 (0) 20 7597 5970

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBSGDRDBGBGXX
Date   Source Headline
1st May 20249:10 amRNSTotal Voting Rights
26th Apr 20249:17 amRNSDirector/PDMR Shareholding
25th Apr 20243:41 pmRNSHolding(s) in Company
17th Apr 20243:30 pmRNSHolding(s) in Company
4th Apr 20243:17 pmRNSHolding(s) in Company
2nd Apr 20242:47 pmRNSDirector/PDMR and PCA Shareholding
28th Mar 20245:04 pmRNSTotal Voting Rights
18th Mar 202412:35 pmRNSDirector/PDMR Shareholding
13th Mar 20247:03 amRNSProposed acquisition of Peters Surgical
13th Mar 20247:03 amRNSUnaudited Preliminary Results
12th Mar 20247:00 amRNSBlock listing Interim Review
10th Jan 20247:00 amRNSFull Year Trading Update
30th Nov 20235:11 pmRNSTotal Voting Rights
31st Oct 20235:02 pmRNSTotal Voting Rights
25th Oct 20237:00 amRNSUS LiquiBand® distribution agreements signed
2nd Oct 20237:01 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSAppointment of New Chair
27th Sep 20235:55 pmRNSDirector/PDMR Shareholding
25th Sep 20233:15 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSLiquiBand Fix8® US commercialisation agreement
14th Sep 20233:52 pmRNSBlock listing Interim Review
4th Sep 20237:00 amRNSTrading Statement
31st Aug 20235:56 pmRNSTotal Voting Rights
10th Aug 20237:00 amRNSNotice of Interim Results
31st Jul 20234:51 pmRNSTotal Voting Rights
11th Jul 20237:00 amRNSHalf Year Trading Update
30th Jun 20232:14 pmRNSTotal Voting Rights
19th Jun 202312:18 pmRNSStandard form for notification of major holdings
5th Jun 20237:00 amRNSUS regulatory approval granted for LiquiBandFix8®
31st May 20232:08 pmRNSResults of Annual General Meeting
31st May 20237:00 amRNSAnnual General Meeting
22nd May 20236:13 pmRNSDirector/PDMR Shareholding
28th Apr 20235:57 pmRNSTotal Voting Rights
26th Apr 20235:37 pmRNSAnnual Report and Notice of Annual General Meeting
18th Apr 20236:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:41 pmRNSTotal Voting Rights
27th Mar 20235:56 pmRNSDirector/PDMR and PCA Shareholding
22nd Mar 20235:52 pmRNSDirector/PDMR Shareholding
15th Mar 20237:00 amRNSUnaudited Preliminary Results
8th Mar 20232:56 pmRNSBlock listing announcement
28th Feb 20235:56 pmRNSTotal Voting Rights
14th Feb 20237:01 amRNSNotice of Results
1st Feb 20231:30 pmRNSAcquisition of Connexicon Medical
31st Jan 20233:17 pmRNSTotal Voting Rights
10th Jan 20237:00 amRNSFull Year Trading Update
3rd Jan 20237:00 amRNSTotal Voting Rights
30th Nov 20226:04 pmRNSTotal Voting Rights
28th Nov 20224:20 pmRNSChange of Registrar
31st Oct 20227:00 amRNSLiquiBandFix8® PMA application accepted by FDA

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.